Thyrocare Technologies (NSE:THYROCARE) EV-to-Revenue : 5.51 (As of May. 29, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Thyrocare Technologies's enterprise value is ₹31,518 Mil. Thyrocare Technologies's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹5,719 Mil. Therefore, Thyrocare Technologies's EV-to-Revenue for today is 5.51.

The historical rank and industry rank for Thyrocare Technologies's EV-to-Revenue or its related term are showing as below:

NSE:THYROCARE' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.13 Med: 8.15 Max: 15.29
Current: 5.51

During the past 10 years, the highest EV-to-Revenue of Thyrocare Technologies was 15.29. The lowest was 4.13. And the median was 8.15.

NSE:THYROCARE's EV-to-Revenue is ranked worse than
68.92% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.195 vs NSE:THYROCARE: 5.51

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-29), Thyrocare Technologies's stock price is ₹621.20. Thyrocare Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹108.44. Therefore, Thyrocare Technologies's PS Ratio for today is 5.73.

Thyrocare Technologies EV-to-Revenue Historical Data

The historical data trend for Thyrocare Technologies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies EV-to-Revenue Chart

Thyrocare Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-Revenue

Get a 7-Day Free Trial

5.89

9.43

6.76

4.10

5.22

Thyrocare Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															4.10	5.14	5.40	6.16	5.22

Competitive Comparison of Thyrocare Technologies's EV-to-Revenue

For the Diagnostics & Research subindustry, Thyrocare Technologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thyrocare Technologies's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's EV-to-Revenue falls into.

Thyrocare Technologies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Thyrocare Technologies's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	31517.776	/	5718.8
	=	5.51

Thyrocare Technologies's current Enterprise Value is ₹31,518 Mil.
Thyrocare Technologies's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,719 Mil.

Thyrocare Technologies (NSE:THYROCARE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Thyrocare Technologies's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	621.20	/	108.436
	=	5.73

Thyrocare Technologies's share price for today is ₹621.20.
Thyrocare Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹108.44.

Thyrocare Technologies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Thyrocare Technologies (NSE:THYROCARE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

539871:India

Address

D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703

Website

https://www.thyrocare.com

Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines